Published 31 October 2008, doi:10.1136/bmj.a2034
Cite this as: BMJ 2008;337:a2034

Editorials

Do patients’ preferences matter?

Yes, but to what extent is unclear

The first 150 words of the full text of this article appear below.

Patients’ preferences are important. Where treatment choices have different and well understood outcomes, what matters most when deciding which treatment is best is the patient’s preference. The intriguing question is whether strong treatment preferences can also affect outcomes—that is, can the preferences themselves exert a therapeutic effect over and above the anticipated effects of compliance and attrition, and if so, by how much? We know very little about this area. In the linked study (doi:10.1136/bmj.a1864), the Preference Collaborative Review Group reviews the effects of patient preferences on attrition and outcomes in trials of patients’ preferences using a meta-analysis of individual patient data.1

We know that the placebo effect can be profound. Its most plausible mechanism of action involves belief in an effect, and this must relate strongly to preferences.2 But a double blind trial of placebo versus nothing is needed to identify a placebo effect. Some meta-analyses have . . . [Full text of this article]

Klim McPherson, visiting professor of public health epidemiology

1 Nuffield Department of Obstetrics and Gynaecology, Oxford University, Womens Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU

klim.mcpherson@obs-gyn.ox.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Relevant Articles

Patients’ preference and mental capacity
Anita Damle
BMJ 2009 338: b385. [Extract] [Full Text]

Patients’ preferences within randomised trials: systematic review and patient level meta-analysis
Preference Collaborative Review Group
BMJ 2008 337: a1864. [Abstract] [Full Text] [PDF]

Synthesising licensing data to assess drug safety
Klim McPherson and Elina Hemminki
BMJ 2004 328: 518-520. [Extract] [Full Text] [PDF]

Incorporating patient preferences into clinical trials
Klim McPherson, Iain Chalmers, Sarah Clement, Jim Sikorski, Jennifer Wilson, Bridget Candy, David J Torgerson, and Bonnie Sibbald
BMJ 1998 317: 78. [Extract] [Full Text]

This article has been cited by other articles:

  • Damle, A. (2009). Patients' preference and mental capacity. BMJ 338: b385-b385 [Full text]  

Rapid Responses:

Read all Rapid Responses

patient preferences in mental health units
Ambreen Aslam
bmj.com, 4 Nov 2008 [Full text]
"randomised evidence is considered most rigorous"
Julian C. Law
bmj.com, 11 Jan 2009 [Full text]
Patient preference and mental capacity
Anita Damle
bmj.com, 12 Jan 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ